Airship Study: No-Code Native App Experiences Double Purchase Frequency (+140%), Offering Path to Profitable Holiday Growth
26.11.2025 00:08:00 CET | Business Wire | Press release
New research quantifies the massive conversion lift from optimizing native app and web experiences, providing a critical no-code path for retailers to drive profitability
Mobile-first customer experience company Airship today released new aggregate data analysis findings showing that no-code native app experiences significantly increase conversion for key lifecycle events and more than double purchase frequency.
The Airship "Experience Impact” research, which studied over 1,000 in-app retail experiences and 1.7 billion device sessions, quantifies the impact of optimizing end-to-end customer journeys—not just sending messages—using no-code and AI-powered tools to drive loyalty and retention at scale, leading to sustainable profitability in a volatile economic environment.
Key Findings
Customers exposed to high-impact no-code native app experiences such as optimized onboarding flows, dynamic surveys, or embedded personalized offers, purchase 140% more frequently than app customers who don’t receive them.
These experiences, which product owners and marketers can create and adapt without developer resources, significantly increase conversion for key lifecycle events and act as a multiplier for purchase conversion rates:
- 2X greater purchase conversion for customers who receive special offer/discount experiences (115% conversion lift)
- 2.5X greater purchase conversion for customers served experiences soliciting their interests and preferences (+179%)
- 3X greater purchase conversion for customers guided to update apps (232%)
- 5X higher purchase conversion for customers encouraged to opt in to push notifications (432%)
The vast majority of retailers agree that app customers tend to make more repeat purchases, are more loyal compared to non-app customers, and are more willing to share their first-party data. Furthermore, Black Friday is the top day of the year for customers to install shopping apps for more than a decade.
Yet any Black Friday app acquisition advantage is typically erased by Christmas, because most retailers treat new holiday installers the same as other customers, essentially allowing them to remain transactionally focused. This results in new app customers acquired during the Cyber Week peak of holiday shopping having lower activation, engagement and retention rates than customers acquired at other times of the year. This is a decisive moment as recent polling from the National Retail Federation finds 63% of shoppers are waiting until Thanksgiving weekend to do most of their holiday buying this year. With consumer uncertainty high and acquisition costs soaring, brands cannot afford to lose these hard-won customers. The key to profitable growth lies in retention and increasing customer lifetime value (CLV).
The Challenge Most Teams Face
Across industries, marketers struggle to improve app experiences quickly because they’re dependent on developer queues, which slows onboarding, preference collection and experimentation, stunting both conversion and retention gains.
Airship solves this challenge by enabling non-technical teams to create, test and optimize these high-impact app and website experiences to quickly turn holiday acquisition into personalized onboarding and loyalty-driving journeys at scale. The Airship Experience Platform (AXP) empowers marketers and product owners to use a no-code Experience Editor to build and embed rich, native app and web content. New Airship AI Agents automate the entire creation-to-optimization process, with Scene AI Agent and Experimentation AI Agent closing the loop between testing, learning and action at a speed and scale that was previously impossible.
Recently Airship was recognized for the first time ever in the 2025 Gartner® Magic Quadrant™ for Multichannel Marketing Hubs1, which the company believes signals a market shift toward intelligent platforms that unify messaging, experiences and data. Get the full, complimentary report here.
Why This Drives Profitable Growth Now
Airship’s lifecycle benchmarks show the mechanics behind profitable retention: opted-in customers purchase more frequently, and identified users buy 41% more often than anonymous users, while apps running onboarding campaigns achieve 78% more identified users than their category average—amplifying downstream conversion and CLV. Additionally, campaigns that leverage customer preferences for audience targeting see a 59% lift in purchase conversion, with top performers reaching an impressive 91%.
With Airship, teams put seamless, mobile-first customer experience into practice faster: designing app and web experiences alongside cross-channel messaging to drive more conversions and preference capture, while continuously optimizing customers’ entire experience with AI.
“Cyber Week provides the attention, but profitable growth only materializes when brands convert those first purchases into durable, long-term customer relationships,” said Maria Robinson, CMO, Airship. “Airship is purpose-built to close that gap. By giving marketers and product teams no-code control of app and web experiences and the AI to optimize them continuously, we turn temporary holiday acquisition into repeat purchases and lasting loyalty.”
Frequently Asked Questions
Why is focusing on in-app experiences so important this holiday season?
With economic volatility and high acquisition costs, profitability is essential. Retailers cannot rely on acquisition alone, as value only accrues later. In the frenzy of holiday deal-hunting, in-session experiences matter most to long-term value. The data shows no-code, native app experiences are the key to retention and higher lifetime value, driving a 140% increase in purchase frequency and boosting opt-ins, user identification and zero-party data collection—all of which create more loyal, high-value customers.
What is the "Experience Gap" Airship solves?
The Experience Gap is the disconnect between what mobile-first customers expect and what brands deliver. Marketing teams send messages to customers, while separate product teams build experiences for them, with little connection between the two workflows. Airship's platform is purpose-built to solve this by unifying the creation of native app and web experiences with cross-channel messaging, optimizing the entire journey where value is actually created: on a brand’s app and website.
How do Airship AI Agents help marketers?
Airship AI Agents automate the creation, testing, and optimization of the entire customer experience. For example, the Scene AI Agent can instantly generate a multi-screen holiday onboarding flow from a simple prompt. The Experimentation AI Agent can then automatically and continuously test variants of that experience to optimize for conversion or any goal. This allows marketers to move at a speed and scale that was previously impossible.
About Airship
Airship is trusted by the world’s leading brands such as Alaska Airlines, BBC, and The Home Depot for mobile-first expertise powering seamless, cross-channel customer experiences that drive business outcomes and earn customer loyalty.
Airship’s mobile-first customer experience platform allows anyone to build, orchestrate, and optimize hyper-personalized end-to-end customer journeys across all channels: email, push notifications, SMS, RCS, mobile wallets, and more, through to app and web experiences where conversion results in value.
Airship’s modular network of AI agents accelerate marketing, product, and growth teams’ efforts to continuously enrich customer data and rapidly launch experiments, optimizing every interaction and business outcome from growing repeatable conversions and customer lifetime value, to fueling durable business growth.
For more information visit www.airship.com.
1Gartner “Magic Quadrant for Multichannel Marketing Hubs,” by Audrey Brosnan, Tia Smart, Suzanne Schwartz, Greg Carlucci, Julian Poulter, Matt Moorut, Julia Multedo, 22 September 2025
Gartner Disclaimers
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251125311730/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom